While GLP-1 medications may cause headaches in some users, some early research is exploring whether GLP-1related mechanisms could influence certain headache conditions, particularly those living with obesity-related migraine or a condition called idiopathic intracranial hypertension (IIH) (which causes chronic headaches due to elevated pressure around the brain)
Wegovy is given as a once-weekly pen injection that is started at a dose of 0.25mg over four weeks
Apps like the GLP-1 app bring together shot reminders, injection-site logging, protein goals, water tracking, and symptom notes
Retatrutide does not have a legitimate monthly retail price because it is investigational, not FDA-approved, and not commercially available
We review your health history, current medications, and weight loss goals to confirm semaglutide is the right fit